Cash And Equivalent Cambiamento Data
Abbott USD 7.84B 1.33B 2023-06
Acorda Therapeutics USD 25.27M 4.98M 2023-06
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
Enanta Pharmaceuticals USD 85.39M 9.79M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Heron Therapeutics USD 34.86M 21.4M 2023-09
Insmed USD 482.37M 4.74M 2023-12
Integra LifeSciences USD 276.4M 2.67M 2023-12
Intrexon USD 10.08M 6.47M 2023-09
J&J USD 3.5B 497M 2023-09
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Merit Medical Systems USD 587.04M 528.36M 2023-12
Peregrine Pharmaceuticals USD 31.42M 6.53M 2023-09
Rigel Pharmaceuticals USD 45.41M 3.4M 2023-09
Stryker USD 2.94B 1.08B 2023-12
Surmodics USD 41.42M 3.16M 2023-09
Veracyte USD 216.45M 13.99M 2023-12
Xencor USD 53.79M 1.06M 2023-12
Zimmer Biomet Holdings USD 415.8M 123.7M 2023-12



Anika Therapeutics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.